For older adults, the flu vaccine could look a little different this year.
The Food and Drug Administration just approved the new type of flu vaccine for adults ages 50 and older. It relies on the ...
Moderna’s newly approved vaccine could allow manufacturers to respond more rapidly to changing influenza strains.
The shot, made by Moderna, will be available for this year's upcoming flu season.
An mRNA-based flu (influenza) vaccine for adults 50 and over, Moderna’s mFLUSIVA, was approved by the U.S. Food and Drug Administration (FDA) on August 5. The approval offers older adults, who are at ...
The approval of the vaccine, called mFLUSIVA, which is manufactured by Moderna, follows a series of blows to mRNA research ...
The agency's former top vaccine regulator declined to review the Moderna shot, and it's now likely to face pushback from ...
Dr. Anthony Fauci texted health officials about a theoretical miscarriage risk from fever after the second mRNA dose in ...
The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA ...
The FDA has approved mFlusiva, the first mRNA-based influenza vaccine, for adults aged 50 years and older, with accelerated approval for those 65 and older.
The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.
The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results